The Truveta Genome Project aims to establish the world’s largest and most diverse database of genetic information.

Health data company Truveta is partnering with health systems and drugmakers to create a massive database of genetic data ...

The health care tech company launched just five years ago but is now valued at more than $1 billion after its latest funding ...

The Fortune 500 pharma giant will sequence the exomes of 10 million people, with the goal of developing new therapies and ...

Seventeen health systems, including Advocate Health, CommonSpirit Health, Henry Ford Health, Northwell Health, Providence and ...

Several large drugmakers will ask the Trump administration to pause Medicare drug-price negotiations, even as Biden-appointed ...

New York: Medical data research company Truveta said on Monday that Regeneron Pharmaceuticals , Illumina and 17 U.S. health systems will take a $320 million stake in the company as part of a deal ...

Regeneron Pharmaceuticals said it is collaborating with Truveta and its network of U.S. health systems to extend its DNA sequence-linked healthcare database. The company said Monday that it will ...

Regeneron and Illumina have joined a major investment in health data specialist Truveta that will support the creation of a major new genome project. The two companies, along with 17 US health ...

Thus far 2025 has come roaring in as far as large rounds go. Last week more than a dozen companies raised $100 million or ...

If all goes as planned, Myerson says, the Truveta Genome Project will unlock insights into patient care and propel drug discovery. “The world needed this to exist,” Myerson says. The Regeneron ...